Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR-4: Estradiol for Perimenstrual Suicidality
NCT06191289Phase 2Terminated
- Sponsor
- University of Illinois Chicago
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol in suicidal ideation, sponsored by University of Illinois Chicago. Started Mar 2024; status: terminated.
02
Drugs
estradiol
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT06191289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06191289.